New Mexico's Department of Health Center for Medical Cannabis and Psilocybin began accepting applications last week from prospective producers seeking to grow psilocybin mushrooms for the state's new medical program, marking an early step toward making the program operational.
New Mexico opens producer applications for medical psilocybin program
New Mexico's Department of Health Center for Medical Cannabis and Psilocybin began accepting applications last week from prospective producers seeking to grow psilocybin mushrooms for the state's new medical program, marking an early step toward making the program operational.
The program was established when Senate Bill 219 was signed into law last year, creating a medical psilocybin program, an advisory board, and legalizing the use of psilocybin in controlled therapeutic settings. Qualifying conditions currently include major treatment-resistant depression, post-traumatic stress disorder, substance use disorders, and end-of-life care.
SB219 set a statutory implementation deadline of December 31, 2027, but the state committed to expediting that timeline by one year, aiming to open the program to its first patients by the end of 2026.
According to the permit requirements, applicants must provide a state business license; proof of registration with the New Mexico Secretary of State and the Taxation and Revenue Department; facility safety documents; proof of ownership or a signed statement from the landowner; proof of compliance with city and county zoning requirements; and verification that psilocybin products will only be produced and tested in New Mexico. A Department of Health spokesperson told Source NM by email that there is currently no deadline for applications and that submissions will be reviewed in order of receipt.
Santa Fe-based psychedelic attorney Victoria Cvitanovic told Source NM that the program's rulemaking process is not yet complete and that additional permit applications for testing and for qualified clinicians will open in the future. A buildout and inspection period is also expected before patient treatment begins.
- The source does not state how many producer applications have been submitted since the application period opened.
- The source does not state what fees, if any, are associated with the producer permit application.
- The source does not state the specific criteria by which applications will be evaluated or approved beyond the listed documentation requirements.
- The source does not state what the buildout and inspection period will involve or how long it is expected to take.
- The source does not state what financial or facility investment would be required to become a producer.
- The source does not state how many licensed producers or clinicians the program expects to certify initially.
Read the original at Marijuana Moment